Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Eli Lilly's New Diabetes Drug
Yahoo/CNBC
Saturday, June 26, 2010 - 9:25am
tags:
Eli Lilly, Bydureon, Byetta
Merck Breathes Life Into an Acquired Pipeline
Motley Fool
Saturday, June 26, 2010 - 9:22am
tags:
Merck, Dulera, asthma, Novartis, Fordadil, Symbicort, Advair, AstraZeneca, GSK, COPD
Mark Your Calendars: Obesity Drugs Take Center Stage
Motley Fool
Saturday, June 26, 2010 - 9:17am
tags:
obesity, Orexigen, Qnexa, Vivus, Abbott Laboratories, GSK, Meridia, Alli
What Investors Think About Vical
Motley Fool
Saturday, June 26, 2010 - 9:14am
tags:
Vical, investors
Diabetes drug makers gain ahead of conference
MarketWatch
Saturday, June 26, 2010 - 9:13am
tags:
Arca pharmaceutical index, MannKind, Amylin, Molecular Insight, diabetes
Neuralstem plans to sell $10M in stock units
Yahoo/AP
Saturday, June 26, 2010 - 9:12am
tags:
Neuralstem, investors
Corcept Therapeutics plans $15M stock sale
bizjournals.com
Saturday, June 26, 2010 - 9:10am
tags:
Corcept Therapeutics
Gilead Sciences to buy CGI Pharma for up to $120M
Yahoo/AP
Friday, June 25, 2010 - 12:28pm
tags:
Gilead Sciences, M&A, CGI Pharma
Jazz Pharmaceuticals says FDA advisory committee will review potential fibromyalgia drug
Yahoo/AP
Friday, June 25, 2010 - 12:27pm
tags:
Jazz Pharmaceuticals, advisory panels, FDA, fibromyalgia
ImmunoGen gets $1 million from partner
Yahoo/AP
Friday, June 25, 2010 - 12:25pm
tags:
Immunogen, cancer, partnerships, Sanofi
Ending the Silence of Generic Drugmakers
Bloomberg Businessweek
Friday, June 25, 2010 - 12:24pm
tags:
generics, FTC, pay-for-delay
Hidden Upside for Pharmaceutical Pricing in Healthcare Reform
Pharmareform
Friday, June 25, 2010 - 11:27am
tags:
healthcare reform, drug pricing
Partying Like It's 1999: Why Big Pharma's Latest "Me Too" Drug Launches Are Doomed
BNET Pharma
Friday, June 25, 2010 - 11:26am
tags:
me-too drugs, Eli Lilly, Merck, Bayer, Staxyn, Livalo, Kowa, insomnia, erectile dysfunction, statins
Lilly CEO: Diabetes: We’ve Come Far — But Have a Long Way to Go
CNBC
Friday, June 25, 2010 - 11:24am
tags:
Eli Lilly, Pharma CEOs, diabetes, John Lechleiter
Johnson & Johnson: The Best Dividend Growth Stock
Seeking Alpha
Friday, June 25, 2010 - 11:21am
tags:
JNJ, dividends
Latest Senate extenders bill calls for higher Medicaid rebates from drug makers
The Hill
Friday, June 25, 2010 - 10:35am
tags:
Senate, Medicaid, healthcare reform, rebates
AstraZeneca: FDA changes motavizumab review date
Marketwatch
Friday, June 25, 2010 - 10:14am
tags:
FDA, AstraZeneca, motavizumab, RSV, monoclonal antibodies
Sanofi-Aventis signs license deal with Metabolex
Marketwatch
Friday, June 25, 2010 - 10:13am
tags:
Sanofi, licensing, Metabolex, diabetes
J&J won't have supplies for recalled meds in 2010
Yahoo/AP
Friday, June 25, 2010 - 10:12am
tags:
JNJ, recalls
Debate Over Industry Role in Educating Doctors
NY Times, NY
Thursday, June 24, 2010 - 5:11pm
tags:
physicians

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.